• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nephrology (Carlton) . Early Predictors of Acute Kidney Injury in COVID-19 Patients

tetano

Editor, Senior Moderator
Nephrology (Carlton)


. 2021 Jan 27.
doi: 10.1111/nep.13856. Online ahead of print.
Early Predictors of Acute Kidney Injury in COVID-19 Patients


Cigdem Yildirim[SUP] 1 [/SUP], Hasan Selcuk Ozger[SUP] 1 [/SUP], Emre Yasar[SUP] 2 [/SUP], Nazrin Tombul[SUP] 3 [/SUP], Ozlem Gulbahar[SUP] 3 [/SUP], Mehmet Yildiz[SUP] 1 [/SUP], Gulendam Bozdayi[SUP] 4 [/SUP], Ulver Derici[SUP] 2 [/SUP], Murat Dizbay[SUP] 1 [/SUP]



Affiliations

Abstract

Aim: Coronavirus disease 2019 (COVID-19) related to acute kidney injury (AKI) is associated with poor prognosis and an increased risk of mortality. Early predicting COVID-19 related renal dysfunction may affect the prognosis of COVID-19 as well as reducing the risk of AKI. This study aims to determine the frequency of COVID-19 related AKI and to identify the early predictors of AKI.
Methods: This study is a single-center, retrospective, observational study. Hospitalized confirmed COVID-19 patients between 24 March 2020 and 31 May 2020 were included in the study. All patients were evaluated for renal dysfunctions with urine dipstick, protein/creatinine ratio, albumin/creatinine ratio in spot urine, serum cystatin C, serum creatinine level on hospital admission, and 28[SUP]th[/SUP] day of hospital admission. To assess the utility of these parameters to predict AKI, a receiver-operating characteristic curve was generated and the area under the curve (AUC) was calculated.
Results: 348 patients were included. The average incidence of AKI was 4.9% (n=17). The incidence of AKI in mild, moderate and severe COVID-19 cases was 1.3% (n=4), 9.0 % (n=3) and 76.9% (n=10), respectively. Proteinuria was detected in 7.8% (n=27) of patients with a urine dipstick test. In spot urine analysis, proteinuria was found in 20.1% (n=70) of patients. The frequency of persistent proteinuria was 5.2% (n=18). The AUC value of serum cystatin C, D-dimer and albumin/creatinine ratio to predict COVID-19 related AKI were 0.96 (0.90 to 1.0), 0.94 (0.89 to 0.98) and 0.95 (0.91 to 0.98).
Conclusion: In COVID-19 patients with normal serum creatinine levels on hospital admission, albuminuria, serum cystatin C and D-dimer levels may be an early predictor of COVID-19 related AKI and these patients should be monitored closely for AKI. Since the sample size in the AKI group was small, our study results should be confirmed with larger cohort studies.

Keywords: Acute kidney injury; COVID-19; Cystatin C; D-dimer; Proteinuria.
 
Back
Top Bottom